Video

Dr. VanderWalde on the Importance of Multidisciplinary Care in Rectal Cancer

Noam VanderWalde, MD, MS, discusses the importance of implementing multidisciplinary care for patients with rectal cancer.

Noam VanderWalde, MD, MS, an associate professor of radiation oncology at West Cancer Center and Research Institute, discusses the importance of implementing multidisciplinary care for patients with rectal cancer.

The armamentarium in rectal cancer has expanded significantly over the years, explains VanderWalde. Moreover, there is no established standard of care for patients and multiple treatments can be utilized.

As such, treatment decisions should be made in a multidisciplinary setting that includes medical oncologists, surgeons, and radiation oncologists, VanderWalde says. Notably, patient preference, as well as the specific characteristics of their disease, should be taken into account during treatment selection.

Presenting rectal cancer cases in a multidisciplinary clinic, as well as considering expert opinion, could provide the optimal care for patients in this space, concludes VanderWalde.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD